Onyvax Limited Funding Shot for Cell-Based Vaccines
1/14/2008 10:41:45 AM
1/14/2008 - A major grant has been awarded to a UK consortium working to develop predictive manufacturing tools for cell-based cancer vaccines. The UK Technology Strategy Board has awarded £1.1m ($2.2m) to a group led by biotech firm Onyvax, which will combine the expertise of the vaccine specialist with two UK universities and analytics firm LGC to work on the process technology.
comments powered by